President Trump has taken action to reduce the cost of insulin and improve the quality of care for America’s seniors.

As the New York Post reports, Trump slashes cost of insulin for Medicare enrollees to $35 a month. 

“The deal struck with the nation’s insulin manufacturers and health care providers will limit the co-pay for a month’s supply of insulin to $35 — a 66 percent reduction to current costs, White House counselor Kellyanne Conway said.

“The initiative will apply to the 1 in 3 Medicare enrollees who have diabetes, which is approximately 3 million people.”

You can learn more about the President’s work to lower insulin costs for seniors here.

President Trump has been a champion for America’s seniors. In 2019, the President signed an executive order to protect and and improve care for our nation’s seniors.

As Rep. Kevin Brady said then, “I am encouraged by the President’s commitment  to increase available Medicare benefits, promoting new technologies that expand health care access across the country, particularly in rural communities, eliminate fraud and abuse within the system, and put America’s seniors first.”

The Administration has also worked tirelessly during the COVID–19 pandemic to protect America’s seniors. President Trump and his team have taken action to increase testing, provided regulatory relief to medical providers to help speed up medical care, and has ensured seniors can continue to see their doctors for non-COVID related needs.

Want to read more on the fight against Coronavirus? Read our Coronavirus Bulletin here which contains our extensive FAQ about recent federal actions.

Was this message forwarded to you? CLICK HERE to subscribe to our emails.